Table of Contents Author Guidelines Submit a Manuscript
Journal of Biomedicine and Biotechnology
Volume 2012, Article ID 737134, 6 pages
http://dx.doi.org/10.1155/2012/737134
Research Article

AngiotensinII Preconditioning Promotes Angiogenesis In Vitro via ERKs Phosphorylation

1Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, 180 Feng Lin Road, Shanghai 200032, China
2Institutes of Biological Science, Fudan University, 138 Yixueyuan Road, Shanghai 200032, China
3Institute of Shanghai Medical Science and Technology Information, 602 West Jianguo Road, Shanghai 200032, China

Received 26 September 2011; Revised 3 November 2011; Accepted 21 November 2011

Academic Editor: Yujian James Kang

Copyright © 2012 Aili Guan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. Frey and E. N. Olson, “Cardiac hypertrophy: the good, the bad, and the ugly,” Annual Review of Physiology, vol. 65, pp. 45–79, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. D. Levy, R. J. Garrison, D. D. Savage, W. B. Kannel, and W. P. Castelli, “Prognostic implications of echocardiographically determined left ventricular mass in the framingham heart study,” The New England Journal of Medicine, vol. 322, no. 22, pp. 1561–1566, 1990. View at Google Scholar · View at Scopus
  3. M. L. Marcus, S. Koyanagi, and D. G. Harrison, “Abnormalities in the coronary circulation that occur as a consequence of cardiac hypertrophy,” American Journal of Medicine A, vol. 75, no. 3, pp. 62–66, 1983. View at Google Scholar · View at Scopus
  4. R. J. Tomanek, “Response of the coronary vasculature to myocardial hypertrophy,” Journal of the American College of Cardiology, vol. 15, no. 3, pp. 528–533, 1990. View at Google Scholar · View at Scopus
  5. F. J. Giordano, H. P. Gerber, S. P. Williams et al., “A cardiac myocyte vascular endothelial growth factor paracrine pathway is required to maintain cardiac function,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 10, pp. 5780–5785, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. K. G. Shyu, J. Y. Liou, B. W. Wang, W. J. Fang, and H. Chang, “Carvedilol prevents cardiac hypertrophy and overexpression of hypoxia-inducible factor-1α and vascular endothelial growth factor in pressure-overloaded rat heart,” Journal of Biomedical Science, vol. 12, no. 2, pp. 409–420, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. Y. S. Yoon, S. Uchida, O. Masuo et al., “Progressive attenuation of myocardial vascular endothelial growth factor expression is a seminal event in diabetic cardiomyopathy: restoration of microvascular homeostasis and recovery of cardiac function in diabetic cardiomyopathy after replenishment of local vascular endothelial growth factor,” Circulation, vol. 111, no. 16, pp. 2073–2085, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. H. Yue, W. Li, R. Desnoyer, and S. S. Karnik, “Role of nuclear unphosphorylated STAT3 in angiotensin II type 1 receptor-induced cardiac hypertrophy,” Cardiovascular Research, vol. 85, no. 1, pp. 90–99, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. J. F. Ainscough, M. J. Drinkhill, A. Sedo et al., “Angiotensin II type-1 receptor activation in the adult heart causes blood pressure-independent hypertrophy and cardiac dysfunction,” Cardiovascular Research, vol. 81, no. 3, pp. 592–600, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Leri, P. P. Claudio, Q. Li et al., “Stretch-mediated release of angiotensin II induces myocyte apoptosis by activating p53 that enhances the local renin-angiotensin system and decreases the Bcl-2-to-Bax protein ratio in the cell,” The Journal of Clinical Investigation, vol. 101, no. 7, pp. 1326–1342, 1998. View at Publisher · View at Google Scholar
  11. A. Leri, Y. Liu, P. P. Claudio et al., “Insulin-like growth factor-1 induces Mdm2 and down-regulates p53, attenuating the myocyte renin-angiotensin system and stretch-mediated apoptosis,” American Journal of Pathology, vol. 154, no. 2, pp. 567–580, 1999. View at Google Scholar · View at Scopus
  12. Y. Liu, A. Leri, B. Li et al., “Angiotensin II stimulation in vitro induces hypertrophy of normal and postinfarcted ventricular myocytes,” Circulation Research, vol. 82, no. 11, pp. 1145–1159, 1998. View at Google Scholar · View at Scopus
  13. M. Sano, T. Minamino, H. Toko et al., “p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload,” Nature, vol. 446, no. 7134, pp. 444–448, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. X. H. Wang, S. F. Chen, H. M. Jin, and R. M. Hu, “Differential analyses of angiogenesis and expression of growth factors in micro- and macrovascular endothelial cells of type 2 diabetic rats,” Life Sciences, vol. 84, no. 7-8, pp. 240–249, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. F. M. Marelli-Berg, E. Peek, E. A. Lidington, H. J. Stauss, and R. I. Lechler, “Isolation of endothelial cells from murine tissue,” Journal of Immunological Methods, vol. 244, no. 1-2, pp. 205–215, 2000. View at Publisher · View at Google Scholar · View at Scopus
  16. D. L. Brutsaert, “Cardiac endothelial-myocardial signaling: its role in cardiac growth, contractile performance, and rhythmicity,” Physiological Reviews, vol. 83, no. 1, pp. 59–115, 2003. View at Google Scholar · View at Scopus
  17. D. A. Narmoneva, R. Vukmirovic, M. E. Davis, R. D. Kamm, and R. T. Lee, “Endothelial cells promote cardiac myocyte survival and spatial reorganization: implications for cardiac regeneration,” Circulation, vol. 110, no. 8, pp. 962–968, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Lecht, C. Foerster, H. Arien-Zakay, C. Marcinkiewicz, P. Lazarovici, and P. I. Lelkes, “Cardiac microvascular endothelial cells express and release nerve growth factor but not fibroblast growth factor-2,” In Vitro Cellular and Developmental Biology, vol. 46, no. 5, pp. 469–476, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. G. Mall, G. Zimmer, S. Baden, and T. Mattfeldt, “Capillary neoformation in the rat heart—stereological studies on papillary muscles in hypertrophy and physiologic growth,” Basic Research in Cardiology, vol. 85, no. 6, pp. 531–540, 1990. View at Publisher · View at Google Scholar · View at Scopus
  20. P. Carmeliet, “Mechanisms of angiogenesis and arteriogenesis,” Nature Medicine, vol. 6, no. 4, pp. 389–395, 2000. View at Publisher · View at Google Scholar · View at Scopus
  21. G. W. Booz, J. N. Day, and K. M. Baker, “Interplay between the cardiac renin angiotensin system and JAK-STAT signaling: role in cardiac hypertrophy, ischemia/reperfusion dysfunction, and heart failure,” Journal of Molecular and Cellular Cardiology, vol. 34, no. 11, pp. 1443–1453, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Das, R. M. Engelman, N. Maulik, and D. K. Das, “Angiotensin preconditioning of the heart: evidence for redox signaling,” Cell Biochemistry and Biophysics, vol. 44, no. 1, pp. 103–110, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. R. J. Diaz and G. J. Wilson, “Selective blockade of AT1 angiotensin II receptors abolishes ischemic preconditioning in isolated rabbit hearts,” Journal of Molecular and Cellular Cardiology, vol. 29, no. 1, pp. 129–139, 1997. View at Publisher · View at Google Scholar · View at Scopus
  24. A. J. Ferreira, R. A. Santos, and A. P. Almeida, “Angiotensin-(1–7): cardioprotective effect in myocardial ischemia/reperfusion,” Hypertension, vol. 38, no. 3, part 2, pp. 665–668, 2001. View at Google Scholar · View at Scopus
  25. A. Nakano, T. Miura, N. Ura, K. Suzuki, and K. Shimamoto, “Role of the angiotensin II type 1 receptor in preconditioning against infarction,” Coronary Artery Disease, vol. 8, no. 6, pp. 343–350, 1997. View at Google Scholar · View at Scopus
  26. A. Sharma and M. Singh, “Effect of ethylisopropyl amiloride, a Na+-H+ exchange inhibitor, on cardioprotective effect of ischaemic and angiotensin preconditioning,” Molecular and Cellular Biochemistry, vol. 214, no. 1-2, pp. 31–38, 2000. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Sharma and M. Singh, “Possible mechanism of cardioprotective effect of angiotensin preconditioning in isolated rat heart,” European Journal of Pharmacology, vol. 406, no. 1, pp. 85–92, 2000. View at Publisher · View at Google Scholar · View at Scopus
  28. X. H. Xiao and D. G. Allen, “The role of endogenous angiotensin II in ischaemia, reperfusion and preconditioning of the isolated rat heart,” Pflugers Archiv European Journal of Physiology, vol. 445, no. 6, pp. 643–650, 2003. View at Google Scholar · View at Scopus
  29. Y. Liu, A. Tsuchida, M. V. Cohen, and J. M. Downey, “Pretreatment with angiotensin II activates protein kinase C and limits myocardial infarction in isolated rabbit hearts,” Journal of Molecular and Cellular Cardiology, vol. 27, no. 3, pp. 883–892, 1995. View at Google Scholar · View at Scopus